A comprehensive view of Biogen Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Biogen Inc. Leads Industry with MS Workshop in GCC, Endorses Tech in Dementia Care, and Achieves My Green Lab Certification for Sustainable Lab Operations
Published:
April 23, 2024
by Industry Intelligence Inc.
|
INTERNATIONAL PATENT: BIOGEN MA INC. FILES APPLICATION FOR "SYSTEMS AND METHODS FOR CLASSIFICATION OF LESIONS AND FOR PREDICTING LESION DEVELOPMENT"
Published:
April 23, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: THE BROAD INSTITUTE, INC., BIOGEN MA INC. FILES APPLICATION FOR "GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF"
Published:
April 23, 2024
by U.S. Fed News
|
Biogen Inc. Spearheads Industry Discussions on Biosimilars Market Access and Education at the 20th Biosimilar Medicines Conference
Published:
April 20, 2024
by Industry Intelligence Inc.
|
Australia Patent: BIOGEN MA Files Application for 'PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS'
Published:
April 19, 2024
by Australian Government
|
Ask us about our Government & Public Policy market view